Incyte Stock Performance

Relative Risk vs. Return Landscape

If you had invested $ 10,011 in Incyte on December 26, 2025 and sold it today you would have lost $ 949.00 from holding Incyte or given up 9.48% of portfolio value over 90 days. Incyte does not currently generate positive expected returns and carries 2.1104% risk (volatility on return distribution) over a 90-day horizon. In different words, 18% of stocks are less volatile than Incyte, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.This relative risk-return summary reviews how the instrument behaves against its benchmark. It works best as a comparative read on return quality, drawdown exposure, and volatility burden. Given the investment horizon of 90 days Incyte is expected to under-perform the market. In addition to that, the company is 2.49 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.09 per unit of volatility.

Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Incyte has a beta of -0.17. This usually indicates that as returns on the benchmark increase, returns on Incyte tend to move in the opposite direction, though by a smaller magnitude. During a bear market, however, Incyte is likely to outperform the market. Additionally, Incyte has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Incyte

Accurately predicting the stock market is one of the most challenging tasks for investors analyzing Incyte. No single approach dominates, but the practice of forecasting remains an essential element of the investment process. Investors benefit from applying a variety of techniques rather than relying on a single model for Incyte. The practice of comparing forecasts for Incyte builds analytical resilience regardless of which model proves most accurate.

Hype Prediction Low Estimated High 89.26 91.37 93.48 Details

Intrinsic Valuation Low Real High 81.56 94.01 96.12 Details

Naive Forecast Low Next High 89.52 91.63 93.74 Details

Analyst Consensus Low Target High 97.91 107.59 119.43 Details

Peer comparison enriches Incyte analysis by revealing how the company ranks against competitors. Incyte's multiples must be compared to direct competitors to determine genuine value. Superior peer-relative performance is one of the strongest justifications for Incyte's valuation premium. Cross-company comparison is essential to validate or challenge any investment thesis on Incyte.

Primary Risk Indicators

Volatility has been a defining feature of the stock market in recent decades, and Incyte has reflected that pattern. Sudden corrections and sharp rallies have tested many portfolios that include Incyte. A risk management approach built around Incyte's volatility metrics can help investors manage downside exposure. Tracking Incyte's risk indicators over time reveals how the risk profile evolves across market cycles.

Investor Alerts and Insights

For investors following Incyte, automated alerts provide early signals of meaningful shifts in stock dynamics. Incyte notifications highlight material changes that could affect portfolio decisions and overall risk exposure. Investors can customize Incyte alert parameters to match their risk tolerance and investment horizon. Pairing alerts with independent analysis strengthens conviction in Incyte investment decisions.

Price Density Drivers

Incyte Fundamentals Growth